title: Candida albicans can utilize siderophore during candidastasis caused by apotransferrin.
abstract: Ability of iron acquisition of pathogenic microorganisms functions as a virulence factor. Candida albicans, a fungal pathogen that requires iron for growth, is susceptible to growth retardation by high-affinity iron binding proteins such as transferrin. Recently, we reported that C. albicans could utilize the heme as a part of heme-containing proteins dissociated by heme oxygenase, CaHMX1. In search of another pathway that C. albicans can use to bypass the growth regulation produced by iron limitation, this present study examined utilization of non-candidal siderophores such as Desferal and rhodotorulic acid (RA) for acquisition of inorganic iron by the fungus. C. albicans secreting no siderophores was cultured in iron-free (pretreated with apotransferrin for 24 h) (culture medium). Once growth of the yeast reached stasis from iron starvation, a siderophore was added to the culture media. Results showed that cultures containing apotransferrin within a dialysis membrane recovered growth to the level of untreated controls, whereas C. albicans yeast cells in direct contact with soluble iron-free (apo) transferrin recovered growth only partially. When static growth from iron limitation was reached, the addition of siderophore-apotransferrin complex to culture medium also permitted the yeast to recover growth from apotransferrin growth regulation. All the data show that C. albicans can utilize the non-candidal siderophores for iron acquisition under transferrin regulation as can pathogenic bacteria.
authors.affiliation: College of Pharmacy, Dongduk Women's University, Seoul, Korea.
authors.forename: Jue-Hee
authors.initials: JH
authors.lastname: Lee
authors.forename: Yongmoon
authors.initials: Y
authors.lastname: Han
mesh_terms: D001059:Apoproteins / Q000494:pharmacology*; D002176:Candida albicans / Q000187:drug effects* / Q000254:growth & development / Q000378:metabolism; D003676:Deferoxamine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D007501:Iron / Q000378:metabolism; D017262:Siderophores / Q000494:pharmacology*; D013997:Time Factors; D014168:Transferrin / Q000494:pharmacology*
chemical_list: D001059:Apoproteins; D017262:Siderophores; D014168:Transferrin; C028284:apotransferrin; D007501:Iron; D003676:Deferoxamine